Sanctions imposed by international regulatory bodies and warnings over quality control at production sites have hurt sales in the United States where Indian pharmaceutical firms accounted for a third...
from NDTV Profit - Latest https://ift.tt/2OTrVQP
Thursday, August 9, 2018
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment